Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|4|1|47-59

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.4, Iss.1, 2004-03, pp. : 47-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine

By Holtzman Stephen G.  

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 180-186

Springer Publishing Company

Access to resources Recommend Favorite

Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens

By Rahman S.   Engleman E.   Simon J.   McBride W.J.  

European Journal of Pharmacology, Vol. 414, Iss. 1, 2001-02 ,pp. : 37-44

Elsevier

Access to resources Recommend Favorite

Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice

By Mcgeehan Andrew   Janak Patricia   Olive M.  

Psychopharmacology, Vol. 174, Iss. 2, 2004-07 ,pp. : 266-273

Springer Publishing Company

Access to resources Recommend Favorite

Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine

By Irifune M.   Nomoto M.   Fukuda T.  

European Journal of Pharmacology, Vol. 272, Iss. 1, 1995-01 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor

By Garcia de Mateos-Verchere J.   Vaugeois J.-M.   Naudin B.   Costentin J.  

European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. : 255-259

Elsevier

Access to resources Recommend Favorite